ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma.

Johanna Bendell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.